Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peroxisome proliferator-activated receptor delta (PPAR-delta) is a nuclear receptor encoded by the PPARD gene in humans. It functions as a ligand-activated transcription factor that plays a key role in energy metabolism, particularly in adipose tissues. PPAR-delta represents an important therapeutic target with diverse biological functions and potential applications in treating metabolic disorders, though its complex role in cancer biology requires careful consideration when developing targeted therapies.
PPAR-delta activates transcription of various target genes by binding to specific DNA elements. As a nuclear receptor, it binds peroxisome proliferators and other ligands to regulate gene expression.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxisome proliferator-activated receptor delta (PPAR-delta).